{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:31:55Z","timestamp":1780489915792,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ncl.2023.12.005","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T12:36:00Z","timestamp":1704717360000},"page":"497-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Headache Attributed to a Substance or Its Withdrawal"],"prefix":"10.1016","volume":"42","author":[{"given":"Mark","family":"Obermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaza","family":"Katsarava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2023.12.005_bib1","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177\/0333102417738202.","DOI":"10.1177\/0333102417738202"},{"issue":"4","key":"10.1016\/j.ncl.2023.12.005_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102420942238","article-title":"Secondary headache attributed to exposure to or overuse of a substance","volume":"41","author":"Toom","year":"2021","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib3","first-page":"153","article-title":"Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects","volume":"26","author":"Peters","year":"1951","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.ncl.2023.12.005_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1526-4610.1963.hed0204214.x","article-title":"Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases","volume":"2","author":"Horton","year":"1963","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.ncl.2023.12.005_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.59.7.1011","article-title":"Features of medication overuse headache following overuse of different acute headache drugs","volume":"59","author":"Limmroth","year":"2002","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib6","first-page":"802","article-title":"A\u00a0retrospective long-term analysis of the epidemiology and features of drug-induced headache","volume":"246","author":"Evers","year":"1999","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2023.12.005_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000052134","article-title":"Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse","volume":"45","author":"Fritsche","year":"2001","journal-title":"Eur Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-2982.2004.00789.x","article-title":"Medication overuse headache: rates and predictors for relapse in a 4-year prospective study","volume":"25","author":"Katsarava","year":"2005","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1046\/j.1468-2982.2001.00288.x","article-title":"Long-term follow-up of patients treated for chronic headache with analgesic overuse","volume":"21","author":"Pini","year":"2001","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.ncl.2023.12.005_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/01.WNL.0000069924.69078.8D","article-title":"Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study","volume":"61","author":"Zwart","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1526-4610.1988.hed2801060_2.x","article-title":"Does analgesic abuse cause headaches de novo?","volume":"28","author":"Lance","year":"1988","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.ncl.2023.12.005_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10194-010-0264-6","article-title":"Lifting the burden: the first 7 years","volume":"11","author":"Steiner","year":"2010","journal-title":"J\u00a0Headache Pain"},{"issue":"12","key":"10.1016\/j.ncl.2023.12.005_bib13","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1468-2982.2008.01670.x","article-title":"Chronic daily headache in Brazil: a nationwide population-based study","volume":"28","author":"Queiroz","year":"2008","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.ncl.2023.12.005_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0333102412438977","article-title":"The prevalence of primary headache disorders in Russia: a countrywide survey","volume":"32","author":"Ayzenberg","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ncl.2023.12.005_bib15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2147\/NDT.S25463","article-title":"A\u00a0large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns","volume":"7","author":"Muzina","year":"2011","journal-title":"Neuropsychiatric Dis Treat"},{"issue":"4","key":"10.1016\/j.ncl.2023.12.005_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10194-012-0432-y","article-title":"Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache","volume":"13","author":"Jonsson","year":"2012","journal-title":"J\u00a0Headache Pain"},{"issue":"8","key":"10.1016\/j.ncl.2023.12.005_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1468-1331.2012.03681.x","article-title":"Self-medication of regular headache: a community pharmacy-based survey","volume":"19","author":"Mehuys","year":"2012","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2023.12.005_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1468-2982.2003.00651.x","article-title":"Use and misuse of triptans in France: data from the GRIM2000 population survey","volume":"24","author":"Lucas","year":"2004","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.ncl.2023.12.005_bib19","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1526-4610.2006.00442.x","article-title":"Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period","volume":"46","author":"Meskunas","year":"2006","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2011.08.018","article-title":"Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Tr\u00f8ndelag Health Studies","volume":"153","author":"Hagen","year":"2012","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.ncl.2023.12.005_bib21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1177\/0333102417728244","article-title":"A\u00a0systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache","volume":"38","author":"Cargnin","year":"2018","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12868-019-0536-2","article-title":"Altered activity in the nucleus raphe magnus underlies cortical hyperexcitability and facilitates trigeminal nociception in a rat model of medication overuse headache","volume":"20","author":"Potewiratnanond","year":"2019","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/head.12224","article-title":"Pathophysiology of medication overuse headache--an update","volume":"54","author":"Srikiatkhachorn","year":"2014","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.ncl.2023.12.005_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.21897","article-title":"Triptan-induced latent sensitization: a possible basis for medication overuse headache","volume":"67","author":"De Felice","year":"2010","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2023.12.005_bib25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0333102413515344","article-title":"Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache","volume":"34","author":"Green","year":"2014","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1468-2982.2006.01183.x","article-title":"Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures","volume":"26","author":"Ayzenberg","year":"2006","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-018-0661-0","article-title":"Neuroimaging Findings in Patients with Medication Overuse Headache","volume":"22","author":"Lai","year":"2018","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"10.1016\/j.ncl.2023.12.005_bib28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/head.13037","article-title":"Medication Overuse Headache: Pathophysiological Insights from Structural and Functional Brain MRI Research","volume":"57","author":"Schwedt","year":"2017","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.ncl.2023.12.005_bib29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0333102411431309","article-title":"Detoxification for medication overuse headache is the primary task","volume":"32","author":"Olesen","year":"2012","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.ncl.2023.12.005_bib30","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ejp.1383","article-title":"Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial","volume":"23","author":"Engelstoft","year":"2019","journal-title":"Eur J Pain"},{"issue":"7","key":"10.1016\/j.ncl.2023.12.005_bib31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0333102419828994","article-title":"Complete withdrawal is the most effective approach to reduce disability in patients with medication-overuse headache: A randomized controlled open-label trial","volume":"39","author":"Nielsen","year":"2019","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1468-1331.2011.03497.x","article-title":"European Federation of Neurological Societies. Treatment of medication overuse headache--guideline of the EFNS headache panel","volume":"18","author":"Evers","year":"2011","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","article-title":"Pathophysiology, prevention, and treatment of medication overuse headache","volume":"18","author":"Diener","year":"2019","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-1331.2010.03094.x","article-title":"Reduction in medication-overuse headache after short information. The Akershus study of chronic headache","volume":"18","author":"Grande","year":"2011","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1129-2377-14-10","article-title":"Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial","volume":"14","author":"Rossi","year":"2013","journal-title":"J\u00a0Headache Pain"},{"issue":"5","key":"10.1016\/j.ncl.2023.12.005_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jnnp-2014-308548","article-title":"Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial","volume":"86","author":"Kristoffersen","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2023.12.005_bib37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/brain\/awz052","article-title":"Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial","volume":"142","author":"Pijpers","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ncl.2023.12.005_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0333102415593088","article-title":"Treatment of medication-overuse headache: A systematic review","volume":"36","author":"Chiang","year":"2016","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11916-006-0012-4","article-title":"Medication-overuse headache: description, treatment, and relapse prevention","volume":"10","author":"Grazzi","year":"2006","journal-title":"Curr Pain Headache Rep"},{"issue":"12","key":"10.1016\/j.ncl.2023.12.005_bib40","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0333102415617413","article-title":"Integrated multidisciplinary care of headache disorders: A narrative review","volume":"36","author":"Gaul","year":"2016","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.ncl.2023.12.005_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","article-title":"Medication-overuse headache: risk factors, pathophysiology and management","volume":"12","author":"Diener","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2023.12.005_bib42","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1468-2982.2008.01659.x","article-title":"Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study","volume":"28","author":"Rossi","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ncl.2023.12.005_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocn.2019.09.006","article-title":"Predictors of relapse in patients with medication overuse headache in Shanghai: A retrospective study with a 6-month follow-up","volume":"70","author":"Yuan","year":"2019","journal-title":"J\u00a0Clin Neurosci"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3959(89)90067-5","article-title":"Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics","volume":"38","author":"Iversen","year":"1989","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib45","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00004647-200209000-00010","article-title":"The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects","volume":"22","author":"Kruuse","year":"2002","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"issue":"Pt 9","key":"10.1016\/j.ncl.2023.12.005_bib46","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/brain\/123.9.1830","article-title":"Nitric oxide-induced headache in patients with chronic tension-type headache","volume":"123","author":"Ashina","year":"2000","journal-title":"Brain"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2023.12.005_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/brain\/awg009","article-title":"Migraine can be induced by sildenafil without changes in middle cerebral artery diameter","volume":"126","author":"Kruuse","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-1331.1994.tb00053.x","article-title":"A\u00a0nitric oxide donor (nitroglycerin) triggers genuine migraine attacks","volume":"1","author":"Thomsen","year":"1994","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2023.12.005_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1468-1331.2001.00191.x","article-title":"Calcitonin gene-related peptide levels during nitric oxide-induced headache in patients with chronic tension-type headache","volume":"8","author":"Ashina","year":"2001","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib50","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1526-4610.2012.02212.x","article-title":"CGRP and NO in the trigeminal system: mechanisms and role in headache generation","volume":"52","author":"Messlinger","year":"2012","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03007995.2020.1832977","article-title":"Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials","volume":"37","author":"Freynhagen","year":"2021","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.ncl.2023.12.005_bib52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.25.3.239","article-title":"Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration","volume":"25","author":"Somerville","year":"1975","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.ncl.2023.12.005_bib53","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM199210153271601","article-title":"Withdrawal syndrome after the double-blind cessation of caffeine consumption","volume":"327","author":"Silverman","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ncl.2023.12.005_bib54","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1586\/ern.12.100","article-title":"Hypnic headache and caffeine","volume":"12","author":"Holle","year":"2012","journal-title":"Expert Rev Neurother"},{"issue":"13","key":"10.1016\/j.ncl.2023.12.005_bib55","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.1984.03340370043028","article-title":"Caffeine as an analgesic adjuvant","volume":"251","author":"Laska","year":"1984","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib56","first-page":"83","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib57","first-page":"43","article-title":"Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action","volume":"45","author":"Sawynok","year":"1993","journal-title":"Pharmacol Rev"},{"issue":"6739","key":"10.1016\/j.ncl.2023.12.005_bib58","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/bmj.300.6739.1558","article-title":"Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12\u00a0week double blind trial","volume":"300","author":"van Dusseldorp","year":"1990","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/head.12266","article-title":"Opioids in headache","volume":"54","author":"Levin","year":"2014","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2023.12.005_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1468-2982.1994.1401005.x","article-title":"Opiate and opioid use in patients with refractory headache","volume":"14","author":"Ziegler","year":"1994","journal-title":"Cephalalgia"},{"issue":"7906","key":"10.1016\/j.ncl.2023.12.005_bib61","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(75)91558-5","article-title":"Migraine and reproductive hormones throughout the menstrual cycle","volume":"1","author":"Epstein","year":"1975","journal-title":"Lancet"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861923000993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861923000993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T09:29:11Z","timestamp":1712136551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861923000993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0733861923000993"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2023.12.005","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Headache Attributed to a Substance or Its Withdrawal","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2023.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}